What is the operative mortality rate for adult patients undergoing coronary artery bypass grafting (CABG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Operative Mortality in Coronary Artery Bypass Surgery

The operative mortality for isolated CABG surgery ranges from 1.6% to 2.8% in contemporary practice, with rates varying significantly based on patient age, comorbidities, and institutional volume. 1

Contemporary Mortality Rates

Overall Population

  • Isolated CABG mortality: 1.6% to 2.8% for patients aged 50-79 years 1
  • 30-day mortality: 1.46% in recent large cohort studies 2
  • In-hospital mortality: 2.2% to 2.7% across U.S. hospitals (2008-2012) 3

The Society of Thoracic Surgeons (STS) database reports an average perioperative mortality of 3.0% to 4.0% for isolated AVR and 5.5% to 6.8% for AVR plus CABG, though these figures include valve surgery 1. For isolated CABG specifically, contemporary data demonstrates lower mortality rates of approximately 1.9% 2, 3.

Age-Stratified Mortality

Mortality increases substantially with advancing age 1:

  • Ages 50-79 years: 2.8% 1
  • Ages 80-89 years: 7.1% 1
  • Ages ≥90 years: 11.8% overall, but only 7.2% in nonagenarians without high-risk factors (renal failure, IABP requirement, emergency surgery, or peripheral/cerebrovascular disease) 1

Historical data from Toronto Hospital showed operative mortality declining from 7.2% (1982-1986) to 4.4% (1987-1991) in patients over 70 years, with minimal further improvement through 1996 1.

Risk-Stratified Outcomes

Low-Risk Patients

A multi-institutional STS database analysis identified that patients with predicted risk of mortality (PROM) ≤1.27% can achieve the aspirational goal of 1.0% operative mortality 4. This threshold encompasses approximately 57% of CABG patients 4.

High-Risk Patients

The STS PROM calculator demonstrates limited predictive capacity for patients with estimated risk >25%, where observed mortality begins to diverge from expected mortality 4.

Gender Differences

Women experience significantly higher operative mortality than men (4.60% vs 2.53%, p<0.0001), even after adjustment for preoperative risk factors 5. Multivariate analysis confirms women have an odds ratio of 1.61 (95% CI 1.40-1.84) for operative mortality compared to men 5. This persists despite women being less likely to receive internal mammary artery grafts and more likely to present with diabetes, chronic kidney disease, and nonelective surgery 5.

Emergency CABG After Failed PCI

Emergency CABG following failed PCI carries substantially higher mortality 1:

  • In-hospital mortality: 7.8% to 14% 1
  • Emergency CABG rate after PCI: 0.4% in contemporary practice 1

Risk factors for requiring emergency CABG include cardiogenic shock (OR 11.4), acute MI or emergency PCI (OR 3.2-3.8), multivessel disease (OR 2.3-2.4), and type C lesions (OR 2.6) 1.

Long-Term Mortality Perspective

While operative mortality is the immediate concern, long-term outcomes reveal 6:

  • 30-day mortality: 3.2% (13.5-fold higher than general population)
  • 1-year mortality: 2.9% (similar to general population at 2.4%)
  • 10-year mortality: 30.7% (modestly higher than general population at 25.8%)
  • 20-year mortality: 51.1% (substantially higher than general population at 35.6%)

Key Predictors of Mortality

The strongest predictor of post-CABG mortality is preoperative estimated glomerular filtration rate (eGFR) <46.9 mL/min/1.73m², followed by logistic EuroSCORE ≥2.4 2. Additional independent predictors include 2:

  • Older age
  • Lower body mass index
  • Diabetes mellitus
  • Chronic obstructive pulmonary disease
  • Preoperative renal failure requiring dialysis
  • Heart failure
  • Lower left ventricular ejection fraction
  • NYHA class II-IV symptoms

Institutional Volume Effect

Mortality rates are 33% higher in low-volume centers compared to high-volume centers 1. Medicare data from 684 U.S. hospitals demonstrates average in-hospital mortality of 8.8% for patients over 65 years (13.0% in low-volume vs 6.0% in high-volume centers) 1.

Common Pitfalls

The most common in-hospital complication is postoperative hemorrhage (30.4%), which showed a 35.8% relative increase from 2008 to 2012 despite declining rates of cardiac, respiratory, and infectious complications 3. This necessitates heightened attention to bleeding risk stratification and management strategies.

Related Questions

Are the measured kidney dimensions (right kidney 10.9 × 5.7 × 6.6 cm, left kidney 12.1 × 6.2 × 6.2 cm) normal for a 41‑year‑old woman who is 5 ft tall?
What is the cause of a supine blood pressure of 90/58 mm Hg without orthostatic fall in a 54‑year‑old woman?
In a 21-year-old female runner who developed leg pain and progressively spreading bruising, what urgent evaluation and management are indicated?
What is the appropriate evaluation and initial management for a 19‑year‑old male with severe unexplained weight loss?
In a 19‑year‑old female with a three‑month history of progressive right‑temporal headache aggravated by coughing, cold exposure, bright light, and fan airflow, now accompanied by right‑sided painful ophthalmoplegia (intermittent diplopia that resolves when one eye is covered, medial deviation of the right eye, right upper‑eyelid ptosis, and retro‑orbital pain) and no fever or other systemic signs, what is the most likely diagnosis and what urgent investigations and initial management are recommended?
How should ciprofloxacin 0.3% otic solution be used to treat uncomplicated acute otitis externa?
What does an elevated alkaline phosphatase with a normal gamma‑glutamyl transferase indicate and how should it be evaluated?
What is the appropriate rescue dose of diazepam for an adult experiencing a breakthrough or prolonged seizure, and what precautions and monitoring are required?
In a patient with thrombocytopenia, should I reduce the carboplatin target area under the curve (AUC) to lower the dose?
Can cranial nerves be documented as intact if nystagmus is present?
What are the recommended treatment options for polycystic ovary syndrome (PCOS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.